Skip to main content
Erschienen in: Metabolic Brain Disease 3/2019

08.03.2019 | Original Article

Protocatechuic acid attenuate depressive-like behavior in olfactory bulbectomized rat model: behavioral and neurobiochemical investigations

verfasst von: Vishnu N. Thakare, Rajesh R. Patil, Anupama A. Suralkar, Valmik D. Dhakane, Bhoomika M. Patel

Erschienen in: Metabolic Brain Disease | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

The main objective of the present study is to investigate potential effects of PCA in OBX induced depressive-like behavior in rat model. PCA was administered at a dose of 100 mg/kg and 200 mg/kg, by per oral in OBX and sham operated rats. Behavioral (ambulatory and rearing activity and immobility time), neurochemical [serotonin (5-HT), dopamine (DA), norepinephrine (NE) and brain derived neurotrophic factor (BDNF) expression], biochemical (MDA formation, IL-6, TNF-α and antioxidants) changes in hippocampus and cerebral cortex along with serum corticosterone were investigated. Experimental findings reveals that OBX subjected rats showed alteration in behaviors like, increase in immobility time, ambulatory and rearing behaviors significantly, reduced BDNF level, 5-HT, DA,NE and antioxidant parameters along with increased serum corticosterone, MDA formation, IL-6, and TNF-α in hippocampus and cerebral cortex compared to sham operated rats. Administration of PCA significantly attenuated behavioral and neurobiochemical alterations, thus, its antidepressant-like activity is largely mediated through modulation of neurotransmitter, endocrine and immunologic systems, mainly by improvements of BDNF, 5-HT, DA, NE, reduced MDA, IL-6, and TNF-α in hippocampus and cerebral cortex.
Literatur
Zurück zum Zitat Antunes MS, Jesse CR, Ruff JR, de Oliveira Espinosa D, Gomes NS, Altvater EET, Donato F, Giacomeli R, Boeira SP (2016) Hesperidin reverses cognitive and depressive disturbances induced by olfactory bulbectomy in mice by modulating hippocampal neurotrophins and cytokine levels and acetylcholinesterase activity. Eur J Pharmacol 789:411–420CrossRefPubMed Antunes MS, Jesse CR, Ruff JR, de Oliveira Espinosa D, Gomes NS, Altvater EET, Donato F, Giacomeli R, Boeira SP (2016) Hesperidin reverses cognitive and depressive disturbances induced by olfactory bulbectomy in mice by modulating hippocampal neurotrophins and cytokine levels and acetylcholinesterase activity. Eur J Pharmacol 789:411–420CrossRefPubMed
Zurück zum Zitat Cairncross KD, Wren A, Cox B, Schnieden H (1977) Effects of olfactory bulbectomy and domicile on stress-induced corticosterone release in the rat. Physiol Behav 19:485–487CrossRefPubMed Cairncross KD, Wren A, Cox B, Schnieden H (1977) Effects of olfactory bulbectomy and domicile on stress-induced corticosterone release in the rat. Physiol Behav 19:485–487CrossRefPubMed
Zurück zum Zitat Duman RS (2004) Role of neurotrophic factors in the etiology and treatment of mood disorders. NeuroMolecular Med 5:11–25CrossRefPubMed Duman RS (2004) Role of neurotrophic factors in the etiology and treatment of mood disorders. NeuroMolecular Med 5:11–25CrossRefPubMed
Zurück zum Zitat Elhwuegi AS (2004) Central monoamines and their role in major depression. Prog Neuropsychopharmacol Biol Psychiatry 28:435–451CrossRefPubMed Elhwuegi AS (2004) Central monoamines and their role in major depression. Prog Neuropsychopharmacol Biol Psychiatry 28:435–451CrossRefPubMed
Zurück zum Zitat Fernandes BS, Gama CS, Ceresér KM, Yatham LN, Fries GR, Colpo G et al (2011) Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis. J Psychiatr Res 45:995–1004CrossRefPubMed Fernandes BS, Gama CS, Ceresér KM, Yatham LN, Fries GR, Colpo G et al (2011) Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis. J Psychiatr Res 45:995–1004CrossRefPubMed
Zurück zum Zitat Fuchs E, Czéh B, Kole MH et al (2004) Alterations of neuroplasticity in depression: the hippocampus and beyond. Eur Neuropsychopharmacol 14:S481–S490CrossRefPubMed Fuchs E, Czéh B, Kole MH et al (2004) Alterations of neuroplasticity in depression: the hippocampus and beyond. Eur Neuropsychopharmacol 14:S481–S490CrossRefPubMed
Zurück zum Zitat Jindal A, Mahesh R, Bhatt S (2015a) Type 4 phosphodiesterase enzyme inhibitor, rolipram rescues behavioral deficits in olfactory bulbectomy models of depression: involvement of hypothalamic–pituitary–adrenal axis, cAMP signaling aspects and antioxidant defense system. Pharmacol Biochem Behav 132:20–32CrossRefPubMed Jindal A, Mahesh R, Bhatt S (2015a) Type 4 phosphodiesterase enzyme inhibitor, rolipram rescues behavioral deficits in olfactory bulbectomy models of depression: involvement of hypothalamic–pituitary–adrenal axis, cAMP signaling aspects and antioxidant defense system. Pharmacol Biochem Behav 132:20–32CrossRefPubMed
Zurück zum Zitat Jindal A, Mahesh R, Bhatt S (2015b) Etazolate, a phosphodiesterase-4 enzyme inhibitor produces antidepressant-like effects by blocking the behavioral, biochemical, neurobiological deficits and histological abnormalities in hippocampus region caused by olfactory bulbectomy. Psychopharmacology (Berlin) 232:623–637CrossRef Jindal A, Mahesh R, Bhatt S (2015b) Etazolate, a phosphodiesterase-4 enzyme inhibitor produces antidepressant-like effects by blocking the behavioral, biochemical, neurobiological deficits and histological abnormalities in hippocampus region caused by olfactory bulbectomy. Psychopharmacology (Berlin) 232:623–637CrossRef
Zurück zum Zitat Kaster MP, Gadotti VM, Calixto JB (2012) Depressive-like behavior induced by tumor necrosis factor-α in mice. Neuropharmacol 62:419–426CrossRef Kaster MP, Gadotti VM, Calixto JB (2012) Depressive-like behavior induced by tumor necrosis factor-α in mice. Neuropharmacol 62:419–426CrossRef
Zurück zum Zitat Kim JH, Kim GH, Hwang KH (2012) Monoamine oxidase and dopamine b-hydroxylase inhibitors from the fruits of Gardenia jasminoides. BiomolTher 20:214–219 Kim JH, Kim GH, Hwang KH (2012) Monoamine oxidase and dopamine b-hydroxylase inhibitors from the fruits of Gardenia jasminoides. BiomolTher 20:214–219
Zurück zum Zitat Kim YS, Seo HW, Lee MH, Kim DK, Jeon H, Cha DS (2014) Protocatechuic acid extends lifespan and increases stress resistance in Caenorhabditis elegans. Archives of Pharmacal Research 37(2):245–252 Kim YS, Seo HW, Lee MH, Kim DK, Jeon H, Cha DS (2014) Protocatechuic acid extends lifespan and increases stress resistance in Caenorhabditis elegans. Archives of Pharmacal Research 37(2):245–252
Zurück zum Zitat Lovell MA, Xie C, Markesbery WR (1998) Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease. Neurology 51(6):1562–1566 Lovell MA, Xie C, Markesbery WR (1998) Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease. Neurology 51(6):1562–1566
Zurück zum Zitat Manji HK, Duman RS (2001) Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics. Psychopharmacol Bull l35:5–49 Manji HK, Duman RS (2001) Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics. Psychopharmacol Bull l35:5–49
Zurück zum Zitat Mao Q, Xian YF, Ip SP et al (2010) Long-term treatment with peony glycosides reverses chronic unpredictable mild stress-induced depressive-like behavior via increasing expression of neurotrophins in rat brain. Behav Brain Res 210:171–177CrossRefPubMed Mao Q, Xian YF, Ip SP et al (2010) Long-term treatment with peony glycosides reverses chronic unpredictable mild stress-induced depressive-like behavior via increasing expression of neurotrophins in rat brain. Behav Brain Res 210:171–177CrossRefPubMed
Zurück zum Zitat Mao QQ, Xian YF, Ip SP, Che CT (2011) Involvement of serotonergic system in the antidepressant-like effect of piperine. Prog Neuropsychopharmacol Biol Psychiatry 35:1144–1147CrossRefPubMed Mao QQ, Xian YF, Ip SP, Che CT (2011) Involvement of serotonergic system in the antidepressant-like effect of piperine. Prog Neuropsychopharmacol Biol Psychiatry 35:1144–1147CrossRefPubMed
Zurück zum Zitat Mao QQ, Huang Z, Zhong X et al (2014) Brain-derived neurotrophic factor signalling mediates the antidepressant-like effect of piperine in chronically stressed mice. Behav Brain Res 26:140–145CrossRef Mao QQ, Huang Z, Zhong X et al (2014) Brain-derived neurotrophic factor signalling mediates the antidepressant-like effect of piperine in chronically stressed mice. Behav Brain Res 26:140–145CrossRef
Zurück zum Zitat Matrisciano F, Bonaccorso S, Ricciardi A, Scaccianoce S, Panaccione I, Wang L, Ruberto A, Tatarelli R, Nicoletti F, Girardi P, Shelton RC (2009) Changes in BDNF serum levels in patients with major depression disorder MDD after 6months treatment with sertraline escitalopram or venlafaxine. J Psychiatr Res 43:247–254CrossRefPubMed Matrisciano F, Bonaccorso S, Ricciardi A, Scaccianoce S, Panaccione I, Wang L, Ruberto A, Tatarelli R, Nicoletti F, Girardi P, Shelton RC (2009) Changes in BDNF serum levels in patients with major depression disorder MDD after 6months treatment with sertraline escitalopram or venlafaxine. J Psychiatr Res 43:247–254CrossRefPubMed
Zurück zum Zitat Muley MM, Thakare VN, Patil RR, Kshirsagar AD, Naik SR (2012) Silymarin improves the behavioural, biochemical and histoarchitecture alterations in focal ischemic rats: comparative evaluation with piracetam and protocatachuic acid. Pharmacol Biochem Behav 102:286–293CrossRefPubMed Muley MM, Thakare VN, Patil RR, Kshirsagar AD, Naik SR (2012) Silymarin improves the behavioural, biochemical and histoarchitecture alterations in focal ischemic rats: comparative evaluation with piracetam and protocatachuic acid. Pharmacol Biochem Behav 102:286–293CrossRefPubMed
Zurück zum Zitat Muley MM, Thakare VN, Patil RR, Bafna PA, Naik SR (2013) Amelioration of cognitive, motor and endogenous defense functions with silymarin, piracetam and protocatechuic acid in the cerebral global ischemic rat model. Life Sci 93:51–57CrossRefPubMed Muley MM, Thakare VN, Patil RR, Bafna PA, Naik SR (2013) Amelioration of cognitive, motor and endogenous defense functions with silymarin, piracetam and protocatechuic acid in the cerebral global ischemic rat model. Life Sci 93:51–57CrossRefPubMed
Zurück zum Zitat Numakawa T, Matsumoto T, Numakawa Y, Richards M, Yamawaki S, Kunugi H (2011) Protective Action of Neurotrophic Factors and Estrogen against Oxidative Stress-Mediated Neurodegeneration. Journal of Toxicology 2011:1–12 Numakawa T, Matsumoto T, Numakawa Y, Richards M, Yamawaki S, Kunugi H (2011) Protective Action of Neurotrophic Factors and Estrogen against Oxidative Stress-Mediated Neurodegeneration. Journal of Toxicology 2011:1–12
Zurück zum Zitat Nutt DJ (2008) Relationship of neurotransmitters to the symptoms of major depressive disorder. J Clin Psychiatry 69:4–7CrossRefPubMed Nutt DJ (2008) Relationship of neurotransmitters to the symptoms of major depressive disorder. J Clin Psychiatry 69:4–7CrossRefPubMed
Zurück zum Zitat Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358CrossRefPubMed Ohkawa H, Ohishi N, Yagi K (1979) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95:351–358CrossRefPubMed
Zurück zum Zitat Pariante CM, Lightman SL (2008) The HPA axis in major depression: classical theories and new developments. Trends Neurosci 31:464–468CrossRefPubMed Pariante CM, Lightman SL (2008) The HPA axis in major depression: classical theories and new developments. Trends Neurosci 31:464–468CrossRefPubMed
Zurück zum Zitat Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327–336PubMed Porsolt RD, Bertin A, Jalfre M (1977) Behavioral despair in mice: a primary screening test for antidepressants. Arch Int Pharmacodyn Ther 229:327–336PubMed
Zurück zum Zitat Rang HP, Dale MM, Ritter JM, Flower RJ (2007) Selective serotonin reuptake inhibitors. Pharmacology, pp 566. Churchill Livingstone, Elsevier Publication Rang HP, Dale MM, Ritter JM, Flower RJ (2007) Selective serotonin reuptake inhibitors. Pharmacology, pp 566. Churchill Livingstone, Elsevier Publication
Zurück zum Zitat Rinwa P, Kumar A (2014) Panax quinquefolium involves nitric oxide pathway in olfactory bulbectomy rat model. Physiol Behav 129:142–151CrossRefPubMed Rinwa P, Kumar A (2014) Panax quinquefolium involves nitric oxide pathway in olfactory bulbectomy rat model. Physiol Behav 129:142–151CrossRefPubMed
Zurück zum Zitat Rodrigues ALS, Rocha JBT, Mello CF, Souza DO (1996) Effect of perinatal Lead exposure on rat behaviour in open-field and two-Wky avoidance tasks. Basic Clin Pharmacol Toxicol 79:150–156CrossRef Rodrigues ALS, Rocha JBT, Mello CF, Souza DO (1996) Effect of perinatal Lead exposure on rat behaviour in open-field and two-Wky avoidance tasks. Basic Clin Pharmacol Toxicol 79:150–156CrossRef
Zurück zum Zitat Rosa JM, Dafre AL, Rodrigues AL (2013) Antidepressant-like responses in the forced swimming test elicited by glutathione and redox modulation. Behavioural Brain Research 253:165–172 Rosa JM, Dafre AL, Rodrigues AL (2013) Antidepressant-like responses in the forced swimming test elicited by glutathione and redox modulation. Behavioural Brain Research 253:165–172
Zurück zum Zitat Schiepers OJ, Wichers MC, Maes M (2005) Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 29:201–217CrossRefPubMed Schiepers OJ, Wichers MC, Maes M (2005) Cytokines and major depression. Prog Neuropsychopharmacol Biol Psychiatry 29:201–217CrossRefPubMed
Zurück zum Zitat Shellenberger MK, Gordon JH (1971) A rapid, simplified procedure for simultaneous assay of norepinephrine, dopamine, and 5-hydroxytryptamine from discrete brain areas. Anal Biochem 39:356–372CrossRefPubMed Shellenberger MK, Gordon JH (1971) A rapid, simplified procedure for simultaneous assay of norepinephrine, dopamine, and 5-hydroxytryptamine from discrete brain areas. Anal Biochem 39:356–372CrossRefPubMed
Zurück zum Zitat Shen J, Ma LG, Hu CY, Pei YY, Jin SL, Fang XY, Li YC (2016) Berberine up-regulates the BDNF expression in hippocampus and attenuates corticosterone-induced depressive-like behavior in mice. Neurosci Lett 614:77–82CrossRefPubMed Shen J, Ma LG, Hu CY, Pei YY, Jin SL, Fang XY, Li YC (2016) Berberine up-regulates the BDNF expression in hippocampus and attenuates corticosterone-induced depressive-like behavior in mice. Neurosci Lett 614:77–82CrossRefPubMed
Zurück zum Zitat Shi GF, An LJ, Jiang B, Guan SI, Bao YM (2006) Alpinia protocatechuic acid protects against oxidative damage in vitro and reduces oxidative stress in vivo. Neurosci Lett 403:206–210CrossRefPubMed Shi GF, An LJ, Jiang B, Guan SI, Bao YM (2006) Alpinia protocatechuic acid protects against oxidative damage in vitro and reduces oxidative stress in vivo. Neurosci Lett 403:206–210CrossRefPubMed
Zurück zum Zitat Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C, Nakazato M, Watanabe H, Shinoda N, Okada SI, Iyo M (2003) Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 54:70–75CrossRefPubMed Shimizu E, Hashimoto K, Okamura N, Koike K, Komatsu N, Kumakiri C, Nakazato M, Watanabe H, Shinoda N, Okada SI, Iyo M (2003) Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biol Psychiatry 54:70–75CrossRefPubMed
Zurück zum Zitat Song C, Leonard BE (2005) The olfactory bulbectomised rat as a model of depression. Neurosci Biobehav Rev 29:627–647CrossRefPubMed Song C, Leonard BE (2005) The olfactory bulbectomised rat as a model of depression. Neurosci Biobehav Rev 29:627–647CrossRefPubMed
Zurück zum Zitat Tang MM, Lin WJ, Pan YQ, Guan XT, Li YC (2016) Hippocampal neurogenesis dysfunction linked to depressive-like behaviors in a neuroinflammation induced model of depression. Physiol Behav 161:166–173CrossRefPubMed Tang MM, Lin WJ, Pan YQ, Guan XT, Li YC (2016) Hippocampal neurogenesis dysfunction linked to depressive-like behaviors in a neuroinflammation induced model of depression. Physiol Behav 161:166–173CrossRefPubMed
Zurück zum Zitat Thakare VN, Patel BM (2015) Potential targets for the development of novel antidepressants: future perspectives. CNS Neurol Disord Drug Targets 14:270–281CrossRefPubMed Thakare VN, Patel BM (2015) Potential targets for the development of novel antidepressants: future perspectives. CNS Neurol Disord Drug Targets 14:270–281CrossRefPubMed
Zurück zum Zitat Thakare VN, Dhakane VD, Patel BM (2016) Potential antidepressant-like activity of silymarin in the acute restraint stress in mice: modulation of corticosterone and oxidative stress response in cerebral cortex and hippocampus. Pharmacol Rep 68:1020–1027CrossRefPubMed Thakare VN, Dhakane VD, Patel BM (2016) Potential antidepressant-like activity of silymarin in the acute restraint stress in mice: modulation of corticosterone and oxidative stress response in cerebral cortex and hippocampus. Pharmacol Rep 68:1020–1027CrossRefPubMed
Zurück zum Zitat Thakare VN, Dhakane VD, Patel BM (2017a) Attenuation of acute restraint stress-induced depressive like behavior and hippocampal alterations with protocatechuic acid treatment in mice. Metab Brain Dis 32:401–413CrossRefPubMed Thakare VN, Dhakane VD, Patel BM (2017a) Attenuation of acute restraint stress-induced depressive like behavior and hippocampal alterations with protocatechuic acid treatment in mice. Metab Brain Dis 32:401–413CrossRefPubMed
Zurück zum Zitat Thakare VN, Aswar MK, Kulkarni YP, Patil RR, Patel BM (2017b) Silymarin ameliorates experimentally induced depressive like behavior in rats: involvement of hippocampal BDNF signaling, inflammatory cytokines and oxidative stress response. Physiol Behav 179:401–410CrossRefPubMed Thakare VN, Aswar MK, Kulkarni YP, Patil RR, Patel BM (2017b) Silymarin ameliorates experimentally induced depressive like behavior in rats: involvement of hippocampal BDNF signaling, inflammatory cytokines and oxidative stress response. Physiol Behav 179:401–410CrossRefPubMed
Zurück zum Zitat Van Reizen H, Leonard BE (1990) Effects of psychotropic drugs on the behavior and neurochemistry of olfactory bulbectomised rats. Pharmacol Ther 47:21–34CrossRef Van Reizen H, Leonard BE (1990) Effects of psychotropic drugs on the behavior and neurochemistry of olfactory bulbectomised rats. Pharmacol Ther 47:21–34CrossRef
Zurück zum Zitat Youdim MB, Weinstock M (2004) Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation. Neurotoxicology 25:243–250CrossRefPubMed Youdim MB, Weinstock M (2004) Therapeutic applications of selective and non-selective inhibitors of monoamine oxidase A and B that do not cause significant tyramine potentiation. Neurotoxicology 25:243–250CrossRefPubMed
Zurück zum Zitat Zhang H, Li G, Szeto S, Chong C, Quan Q et al (2015) Examining the neuroprotective effects of protocatechuic acid and chrysin on in vitro and in vivo models of Parkinson's disease. Free Radic Biol Med 84:331–333CrossRefPubMed Zhang H, Li G, Szeto S, Chong C, Quan Q et al (2015) Examining the neuroprotective effects of protocatechuic acid and chrysin on in vitro and in vivo models of Parkinson's disease. Free Radic Biol Med 84:331–333CrossRefPubMed
Metadaten
Titel
Protocatechuic acid attenuate depressive-like behavior in olfactory bulbectomized rat model: behavioral and neurobiochemical investigations
verfasst von
Vishnu N. Thakare
Rajesh R. Patil
Anupama A. Suralkar
Valmik D. Dhakane
Bhoomika M. Patel
Publikationsdatum
08.03.2019
Verlag
Springer US
Erschienen in
Metabolic Brain Disease / Ausgabe 3/2019
Print ISSN: 0885-7490
Elektronische ISSN: 1573-7365
DOI
https://doi.org/10.1007/s11011-019-00401-8

Weitere Artikel der Ausgabe 3/2019

Metabolic Brain Disease 3/2019 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.